These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 28028665)

  • 1. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
    Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
    Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The updated treatment strategy for gastric cancer with peritoneal metastasis].
    Ishigami H; Kaisaki S; Kitayama J
    Nihon Geka Gakkai Zasshi; 2012 Jan; 113(1):18-21. PubMed ID: 22413551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
    Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial.
    Kodera Y; Takahashi N; Yoshikawa T; Takiguchi N; Fujitani K; Ito Y; Miyamoto K; Takayama O; Imano M; Kobayashi D; Miyashita Y; Morita S; Sakamoto J
    Gastric Cancer; 2017 Jan; 20(1):190-199. PubMed ID: 26879545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.
    Shinkai M; Imano M; Chiba Y; Hiraki Y; Kato H; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
    Anticancer Res; 2018 Oct; 38(10):5969-5974. PubMed ID: 30275227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with S-1 followed by docetaxel for gastric cancer and CY1P0 peritoneal metastasis after relatively curative surgery.
    Kanazawa Y; Kato S; Fujita I; Onodera H; Uchida E
    J Nippon Med Sch; 2013; 80(5):378-83. PubMed ID: 24189356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative intraperitoneal plus systemic chemotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gastric cancer: phase Ib/II single-arm prospective study.
    Cho M; Kim HS; Jung M; Hyung WJ
    J Gastrointest Surg; 2024 Jul; 28(7):1095-1103. PubMed ID: 38705369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer.
    Peng YF; Imano M; Itoh T; Satoh T; Chiba Y; Imamoto H; Tsubaki M; Nishida S; Yasuda T; Furukawa H
    J Surg Oncol; 2015 Jun; 111(8):1041-6. PubMed ID: 26060133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Cisplatin for Gastric Cancer with Peritoneal Metastasis.
    Kobayashi D; Ishigami H; Kanda M; Tanaka C; Yamaguchi H; Kitayama J; Kodera Y
    Oncology; 2020; 98(1):48-52. PubMed ID: 31487733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    J Surg Oncol; 2012 Jan; 105(1):38-42. PubMed ID: 21882194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multidisciplinary treatment for gastric cancer with peritoneal metastasis].
    Ishigami H; Kitayama J; Yamaguchi H; Emoto S; Watanabe T
    Gan To Kagaku Ryoho; 2012 Dec; 39(13):2460-3. PubMed ID: 23235165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
    Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
    Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
    Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
    Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
    Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
    Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.